<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hoyle, Brian</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">VISION Findings</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-10-27 11:20:52</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">7-8</style></pages><abstract><style  face="normal" font="default" size="100%">The VISION study examined the association of preoperative statin use with 30-day frequency of cardiovascular complications. Data from over 7000 patients who received noncardiac surgery indicate the potential value of preoperative statin use, which was associated with lower 30-day risk of all-cause mortality and myocardial injury at 30 days. VISION was an observational study. Randomized controlled trials are needed.</style></abstract><number><style face="normal" font="default" size="100%">28 suppl 1</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>